SNM has announced a collaboration with the National Comprehensive Cancer Network (NCCN) to advance research for cancer imaging and therapies.
NCCN will work with SNM to qualify imaging sites for upcoming research projects utilizing molecular imaging in clinical trials.
Through its Oncology Research Program (ORP), NCCN obtains funding to support clinical trials at its 21 member institutions. One of its new ORP initiatives is the Specialized Imaging Research Consortium, which aims to advance the treatment of patients with cancer through the clinical application of specialized imaging technologies. SNM's clinical trials network will qualify NCCN member institutions to ensure standardization across sites, SNM said.
